The prominent players operating in the next-generation sequencing market are Illumina (US), Thermo Fisher Scientific (US), PerkinElmer (US), BGI Group (China), and Agilent Technologies (US). In January 2021, BGI Group received the CE mark approval for the Thalassemia Gene Detection Kit (Combinatorial Probe-Anchor Synthesis Sequencing Method), which can be used for the genetic diagnosis of […]
